Stem Cells Translational Medicine

Scope & Guideline

Transforming Discoveries into Clinical Applications

Introduction

Delve into the academic richness of Stem Cells Translational Medicine with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN2157-6564
PublisherOXFORD UNIV PRESS
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2012 to 2024
AbbreviationSTEM CELL TRANSL MED / Stem Cells Transl. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The journal 'Stem Cells Translational Medicine' is dedicated to advancing the field of stem cell research and its application in regenerative medicine. It focuses on the translational aspects of stem cell science, bridging the gap between laboratory research and clinical practice.
  1. Stem Cell Therapy Applications:
    The journal emphasizes the clinical applications of various stem cell types, including mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and their derivatives for treating a wide array of diseases, particularly in regenerative medicine.
  2. Mechanisms of Stem Cell Function:
    Research on the biological mechanisms underlying stem cell differentiation, proliferation, and functionality, including studies on signaling pathways, cellular interactions, and the effects of the microenvironment.
  3. Development of Novel Therapeutics:
    Focus on the development and evaluation of new therapeutic strategies utilizing stem cells, including engineered cell products and cell-derived extracellular vesicles, to enhance treatment efficacy.
  4. Regulatory and Ethical Considerations:
    Exploration of regulatory frameworks, ethical implications, and standardization in the use of stem cells and their derivatives in clinical settings.
  5. Translational Research Methodologies:
    Utilization of innovative research methodologies and technologies, such as 3D bioprinting, bioengineering, and high-throughput screening, to facilitate the translation of stem cell research into clinical practice.
The journal has seen a rise in interest in several emerging themes, reflecting the evolving landscape of stem cell research and its application in translational medicine. These trends highlight novel approaches and areas of research that are gaining traction.
  1. Extracellular Vesicles and Secretomes:
    There is an increasing focus on the therapeutic potential of extracellular vesicles derived from stem cells, particularly in their ability to mediate paracrine effects and provide a cell-free alternative for regenerative therapies.
  2. Personalized Medicine Approaches:
    Research is trending towards personalized medicine, where stem cell therapies are tailored to individual patient profiles, leveraging iPSCs derived from patients for disease modeling and customized treatment strategies.
  3. 3D Bioprinting and Tissue Engineering:
    Innovative methodologies such as 3D bioprinting are emerging as key areas, enabling the creation of complex tissue constructs that can better mimic natural tissue architecture for regenerative applications.
  4. Immunomodulation and Inflammation Control:
    Increasing attention is being paid to the immunomodulatory properties of stem cells, particularly MSCs, in managing inflammation and enhancing tissue repair, highlighting their dual role as both therapeutic agents and modulators of the immune response.
  5. Regenerative Strategies for Specific Diseases:
    Focused research on specific diseases, such as neurodegenerative disorders and chronic inflammatory conditions, is trending, showcasing targeted approaches for using stem cells in precision medicine.

Declining or Waning

While 'Stem Cells Translational Medicine' continues to thrive in various research areas, certain themes are witnessing a decline in publication frequency and focus, reflecting shifts in scientific interest or advancements in related fields.
  1. Basic Stem Cell Biology Studies:
    There has been a noticeable decline in publications strictly focused on fundamental stem cell biology without direct translational implications, as the field shifts towards more applied research.
  2. Non-Cell-Based Therapeutics:
    Research focusing on non-cell-based therapeutic interventions, such as small molecules or traditional drug therapies, is becoming less prominent in the context of the journal's focus on cell-based therapies.
  3. Animal Models in Preclinical Studies:
    There is a diminishing trend in studies that predominantly rely on animal models for testing stem cell therapies, as researchers increasingly seek alternative models that better mimic human physiology.
  4. Single Therapeutic Approaches:
    The trend is moving away from studies advocating single therapeutic approaches, with more research emphasizing combinatorial therapies that integrate multiple modalities for enhanced efficacy.

Similar Journals

Cell Stem Cell

Fostering Global Collaboration in Cutting-Edge Stem Cell Discoveries
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

CYTOTHERAPY

Exploring Breakthroughs in Transplantation and Oncology.
Publisher: ELSEVIER SCI LTDISSN: 1465-3249Frequency: 12 issues/year

CYTOTHERAPY is a distinguished journal published by Elsevier Science Ltd, focusing on the critical fields of cell therapy, transplantation, and regenerative medicine. Since its inception in 1999, the journal has established itself as a vital resource for researchers and practitioners, contributing significantly to advancements in Cancer Research, Cell Biology, Genetics, Immunology, and Oncology. With an impressive range of Q2 rankings across multiple categories and a remarkable Q1 standing in Transplantation for 2023, CYTOTHERAPY delivers high-impact research that addresses the evolving challenges in these fields. While the journal does not offer open access, it remains a reputable avenue for disseminating pivotal studies and reviews that push the boundaries of cell-based therapies. Researchers, clinicians, and students alike will find CYTOTHERAPY an indispensable platform to stay abreast of the latest discoveries and innovations that are shaping the future of medical science.

American Journal of Stem Cells

Transforming stem cell research into real-world applications.
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-4150Frequency: 1 issue/year

American Journal of Stem Cells is a leading multidisciplinary publication dedicated to advancing the field of regenerative medicine and stem cell research. Published by E-CENTURY PUBLISHING CORP, this journal has gained recognition for its commitment to high-quality scientific contributions, achieving impressive rankings within the Scopus database, particularly in the areas of Biochemistry, Genetics and Molecular Biology, and Developmental Biology. With its focus on innovative research, the journal offers crucial insights and developments that appeal to researchers, professionals, and students alike. Although it is not an open-access journal, the American Journal of Stem Cells plays a pivotal role in disseminating impactful findings that define the future of cellular therapies and regenerative methodologies. The journal's past coverage from 2012 to 2017 reflects its dedication to advancing knowledge in key scientific disciplines, making it an essential resource for anyone engaged in the dynamic landscape of stem cell science.

International Journal of Stem Cells

Illuminating the Path to Stem Cell Advancements
Publisher: KOREAN SOC STEM CELL RESEARCHISSN: 2005-3606Frequency: 2 issues/year

The International Journal of Stem Cells is a distinguished peer-reviewed journal dedicated to advancing the field of stem cell research. Published by the Korean Society for Stem Cell Research, this journal has established itself as a vital source of high-quality research since its inception in 2008. Operating under the ISSN 2005-3606 and E-ISSN 2005-5447, the journal caters to a global audience, featuring works that span a diverse array of topics within Cell Biology and Developmental Biology. It is noteworthy that as of 2023, the journal is ranked Q3 in Cell Biology and Q2 in Developmental Biology, highlighting its growing influence and credibility in the scientific community. Given its commitment to facilitating open scientific communication, it is crucial for researchers, professionals, and students to engage with the rigorous research published in this journal as it profoundly impacts the understanding and application of stem cell science. With accessibility to a wealth of innovative studies, the International Journal of Stem Cells remains an indispensable resource for anyone interested in the transformative potential of stem cell research.

Tissue Engineering and Regenerative Medicine

Transforming Research into Revolutionary Therapeutic Strategies
Publisher: KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOCISSN: 1738-2696Frequency: 6 issues/year

Tissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.

CYTOTECHNOLOGY

Fostering Collaboration: Uniting Experts in the Pursuit of Cytotechnology Excellence.
Publisher: SPRINGERISSN: 0920-9069Frequency: 6 issues/year

CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.

Stem Cells International

Empowering Knowledge in Regenerative Biology
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

CELL PROLIFERATION

Fostering Discoveries that Transform Biotechnology
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

Russian Journal of Developmental Biology

Diving deep into the dynamics of development.
Publisher: PLEIADES PUBLISHING INCISSN: 1062-3604Frequency: 6 issues/year

The Russian Journal of Developmental Biology, published by PLEIADES PUBLISHING INC, serves as a significant platform for researchers and professionals engaged in the field of developmental biology. With the ISSN 1062-3604 and E-ISSN 1608-3326, this journal focused on intricate biological processes and dynamic developmental mechanisms from 2005 until 2017. Although its coverage is currently discontinued in Scopus, it remains notable for its contribution to understanding the pivotal roles of biochemistry and molecular genetics within the context of development. As a publication situated in the competitive quartiles of the field and boasting an influential Scopus rank of #77 out of #78, it has made a unique mark in developmental studies. Researchers and academics seeking to enhance their knowledge of historical advancements in the discipline will find the journal a valuable resource, even as it navigates the transition away from active publication.

Journal of Tissue Engineering and Regenerative Medicine

Transforming healthcare through cutting-edge research in tissue engineering.
Publisher: WILEYISSN: 1932-6254Frequency: 12 issues/year

Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.